Skip to main content
Clinical Trials/NL-OMON49290
NL-OMON49290
Completed
Not Applicable

Improving directional hearing of cochlear implant users - Directional hearing for CI users

eids Universitair Medisch Centrum0 sites18 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eids Universitair Medisch Centrum
Enrollment
18
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 20, 2022
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • CI users: measurable residual hearing in the contralateral ear with thresholds
  • of 100 dB HL or better at 125, 250 and 500 Hz
  • Normal\-hearing group: not more than 40 dB loss across frequencies

Exclusion Criteria

  • CI users and normal\-hearing subjects should have no disorders other than a
  • hearing impairment that could affect the study results, such as psychiatric
  • disorders or physical disorders that would limit their ability to undergo
  • testing (e.g., movement disorders or blindness).
  • Normal\-hearing subjects will be excluded if hearing thresholds are too high.

Outcomes

Primary Outcomes

Not specified

Similar Trials